[go: up one dir, main page]

BR0111740A - Terapia combinada contra tumores que compreende derivados de distamicina acriloila substituìda e agentes de alquilação - Google Patents

Terapia combinada contra tumores que compreende derivados de distamicina acriloila substituìda e agentes de alquilação

Info

Publication number
BR0111740A
BR0111740A BR0111740-8A BR0111740A BR0111740A BR 0111740 A BR0111740 A BR 0111740A BR 0111740 A BR0111740 A BR 0111740A BR 0111740 A BR0111740 A BR 0111740A
Authority
BR
Brazil
Prior art keywords
distamycin
substituted
acrylamoyl
derivatives
combination therapy
Prior art date
Application number
BR0111740-8A
Other languages
English (en)
Inventor
Maria Cristina Geroni
Paolo Cozzi
Italo Beria
Original Assignee
Pharmacia Italia Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Italia Spa filed Critical Pharmacia Italia Spa
Publication of BR0111740A publication Critical patent/BR0111740A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

"TERAPIA COMBINADA CONTRA TUMORES QUE COMPREENDE DERIVADOS DE DISTAMICINA ACRILOìLA SUBSTITUìDA E AGENTES DE ALQUILAçãO". A presente invenção provê o uso combinado de derivados de distamicina acriloíla, em particular, derivados de distamicina acriloíla <244>-bromo- e <244>-cloro da fórmula (I), como exposto no relatório descritivo, e um agente de alquilação, no tratamento de tumores. Também é provido o uso da referida combinação no tratamento ou prevenção de metástase ou no tratamento de tumores por inibição de angiogênese.
BR0111740-8A 2000-06-23 2001-06-20 Terapia combinada contra tumores que compreende derivados de distamicina acriloila substituìda e agentes de alquilação BR0111740A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0015447.6A GB0015447D0 (en) 2000-06-23 2000-06-23 Combined therapy against tumors comprising substituted acryloyl derivates and alkylating agents
PCT/EP2001/007064 WO2001097790A2 (en) 2000-06-23 2001-06-20 Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and alkylating agents

Publications (1)

Publication Number Publication Date
BR0111740A true BR0111740A (pt) 2003-07-08

Family

ID=9894288

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0111740-8A BR0111740A (pt) 2000-06-23 2001-06-20 Terapia combinada contra tumores que compreende derivados de distamicina acriloila substituìda e agentes de alquilação

Country Status (28)

Country Link
US (1) US8642580B2 (pt)
EP (1) EP1303307B1 (pt)
JP (1) JP2003535891A (pt)
KR (1) KR100869037B1 (pt)
CN (1) CN100479860C (pt)
AT (1) ATE362365T1 (pt)
AU (2) AU2001281867B2 (pt)
BR (1) BR0111740A (pt)
CA (1) CA2410160C (pt)
CY (1) CY1106713T1 (pt)
CZ (1) CZ301053B6 (pt)
DE (1) DE60128472T2 (pt)
DK (1) DK1303307T3 (pt)
EA (1) EA008502B1 (pt)
EE (1) EE05300B1 (pt)
ES (1) ES2284674T3 (pt)
GB (1) GB0015447D0 (pt)
HK (1) HK1054335B (pt)
HU (1) HUP0301234A2 (pt)
IL (2) IL152956A0 (pt)
MX (1) MXPA02012209A (pt)
NO (1) NO329782B1 (pt)
NZ (1) NZ522999A (pt)
PL (1) PL202053B1 (pt)
PT (1) PT1303307E (pt)
SK (1) SK18342002A3 (pt)
WO (1) WO2001097790A2 (pt)
ZA (1) ZA200209836B (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003055522A1 (en) * 2002-01-02 2003-07-10 Pharmacia Italia Spa Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and protein kinase (serine/threonine kinase) inhibitors
NZ535700A (en) * 2002-04-02 2007-06-29 Nerviano Medical Sciences Srl Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and radiotherapy
MD36Z (ro) * 2008-12-02 2010-01-31 Василе ЖОВМИР Metodă de tratament diferenţiat al carcinomului ductal in situ neinvaziv al glandei mamare
MD23Z (ro) * 2008-12-02 2010-01-31 Василе ЖОВМИР Metodă de tratament diferenţiat al carcinomului lobular in situ neinvaziv al glandei mamare
MD24Z (ro) * 2008-12-02 2010-01-31 Василе ЖОВМИР Metodă de tratament diferenţiat al carcinomului neinvaziv al glandei mamare
MD35Z (ro) * 2008-12-02 2010-01-31 Василе ЖОВМИР Metodă de apreciere a riscului dezvoltării carcinomului neinvaziv in situ al glandei mamare
CN107011358B (zh) * 2012-04-05 2020-05-05 内尔维阿诺医学科学有限公司 新的烷化剂

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56154493A (en) * 1980-04-30 1981-11-30 Shionogi & Co Ltd Novel platinum complex
AT387013B (de) 1985-07-16 1988-11-25 Erba Farmitalia Verfahren zur herstellung von poly-4-aminopyrrol -2-carboxamidoderivaten
CN85103908A (zh) * 1985-07-16 1986-11-05 法米塔利·卡洛·埃尔巴有限公司 制备4′-表多克索红菌素的新方法
GB8612218D0 (en) * 1986-05-20 1986-06-25 Erba Farmitalia Site specific alkylating agents
EP0265719B1 (en) 1986-10-07 1991-03-06 Boehringer Mannheim Italia S.P.A. Pharmaceutical compositions having antineoplastic activity
GB8906709D0 (en) 1989-03-23 1989-05-10 Creighton Andrew M Acryloyl substituted pyrrole derivatives
JP2919867B2 (ja) 1989-09-27 1999-07-19 千寿製薬株式会社 抗腫瘍剤
GB9000644D0 (en) * 1990-01-11 1990-03-14 Erba Carlo Spa New ureido derivatives of poly-4-amino-2-carboxy-1-methyl compounds
IT1272234B (it) 1994-05-02 1997-06-16 Consiglio Nazionale Ricerche Derivati glutationici delle antracicline e procedimento per ottenerli.
GB9416005D0 (en) 1994-08-08 1994-09-28 Erba Carlo Spa Peptidic compounds analogous to distamycin a and process for their preparation
US5880097A (en) 1996-01-04 1999-03-09 Terrapin Techologies, Inc. Tethered prodrugs
JP2000503999A (ja) 1996-02-02 2000-04-04 フアルマシア・エ・アツプジヨン・エツセ・ピー・アー ジスタマイシン誘導体、その調製方法、および抗腫瘍および抗ウイルス剤としてのその使用
GB9610079D0 (en) 1996-05-14 1996-07-17 Pharmacia Spa Distamycin deriratives process for preparing them and their use as antitumor and antiviral agents
GB9615692D0 (en) 1996-07-25 1996-09-04 Pharmacia Spa Acryloyl substituted distamycin derivatives, process for preparing them, and their use as antitumor and antiviral agents
GB9623522D0 (en) * 1996-11-11 1997-01-08 Pharmacia & Upjohn Spa Benzoheterocycle distamycin derivatives process for preparing them and their use as antitumour and antiviral agents
GB9727524D0 (en) * 1997-12-31 1998-02-25 Pharmacia & Upjohn Spa Synergistic antitumor composition containing a biologically active ureido compound
GB9806689D0 (en) 1998-03-27 1998-05-27 Pharmacia & Upjohn Spa Acryloyl derivatives analogous to distamycin,process for preparing them,and their use as antitumour and antiviral agents
GB9806692D0 (en) 1998-03-27 1998-05-27 Pharmacia & Upjohn Spa Benzoheterocyclic distamycin derivatives, process for preparing them and their use as antitumour agents
GB9816652D0 (en) 1998-07-30 1998-09-30 Pharmacia & Upjohn Spa Sulfurated distamycin derivatives process for preparing them and their use as antitumor agents
GB9816653D0 (en) 1998-07-30 1998-09-30 Pharmacia & Upjohn Spa Oxidised sulfurated distamycin derivatives process for preparing them and their use as antitumor agents
GB9928703D0 (en) 1999-12-03 2000-02-02 Pharmacia & Upjohn Spa Acryloyl peptidic derivatives,process for their preparation and their use as antitumour agents
GB0011059D0 (en) 2000-05-08 2000-06-28 Pharmacia & Upjohn Spa Use of substituted acryloyl distamycin derivatives in the treatment of tumours associated with high levels of glutathione
GB0015444D0 (en) * 2000-06-23 2000-08-16 Pharmacia & Upjohn Spa Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and topoisomerase I and II inhibitors
US6576612B1 (en) * 2000-10-02 2003-06-10 Pharmacia Italia S.P.A. Antitumor therapy comprising distamycin derivatives

Also Published As

Publication number Publication date
KR100869037B1 (ko) 2008-11-17
IL152956A (en) 2010-06-30
CN100479860C (zh) 2009-04-22
HK1054335A1 (en) 2003-11-28
ATE362365T1 (de) 2007-06-15
GB0015447D0 (en) 2000-08-16
CZ20024106A3 (cs) 2003-05-14
HK1054335B (zh) 2010-06-11
CA2410160A1 (en) 2001-12-27
EE200200660A (et) 2004-06-15
CN1437485A (zh) 2003-08-20
DE60128472D1 (de) 2007-06-28
CA2410160C (en) 2009-06-02
DK1303307T3 (da) 2007-07-16
HUP0301234A2 (hu) 2003-08-28
EE05300B1 (et) 2010-06-15
EP1303307A2 (en) 2003-04-23
US20030180383A1 (en) 2003-09-25
JP2003535891A (ja) 2003-12-02
SK18342002A3 (sk) 2003-06-03
NZ522999A (en) 2004-10-29
ES2284674T3 (es) 2007-11-16
EA200300061A1 (ru) 2003-04-24
EA008502B1 (ru) 2007-06-29
NO20026077D0 (no) 2002-12-18
AU8186701A (en) 2002-01-02
AU2001281867B2 (en) 2006-02-23
WO2001097790A3 (en) 2002-05-16
US8642580B2 (en) 2014-02-04
PT1303307E (pt) 2007-07-04
WO2001097790A2 (en) 2001-12-27
ZA200209836B (en) 2003-12-04
KR20030011105A (ko) 2003-02-06
DE60128472T2 (de) 2008-01-24
PL365158A1 (en) 2004-12-27
CY1106713T1 (el) 2012-05-23
PL202053B1 (pl) 2009-05-29
MXPA02012209A (es) 2003-06-04
NO20026077L (no) 2002-12-18
CZ301053B6 (cs) 2009-10-21
IL152956A0 (en) 2003-06-24
NO329782B1 (no) 2010-12-13
EP1303307B1 (en) 2007-05-16

Similar Documents

Publication Publication Date Title
BR9812122A (pt) Combinação de inibidor da tirosina quinase e castração quìmica para tratar câncer da próstata
BR0207316A (pt) Derivados de epotilona para o tratamento de tumores refratários
BRPI0413255A (pt) uso de uma combinação de um inibidor de quinase do receptor do fator de crescimento epidérmico e agentes citotóxicos para tratamento e inibição do cáncer
BR0015992A (pt) Compostos, utilização dos mesmos, e, associações terapêuticas
MXPA03002911A (es) Compuestos quimicos.
MXPA02012076A (es) Compuestos quimicos.
AU2001266575A1 (en) Chemical compounds
BR0011225A (pt) Agente para tratar de olhos secos, seu método e uso
CY1106713T1 (el) Συνδυασμενη θεραπεια εναντιον καρκινωματων η οποια περιλαμβανει παραγωγα υποκαταστημενης ακρυλοϋλ δισταμυσινης και αλκυλιωτικους παραγοντες
AR020563A1 (es) Compuestos (poli)tia-alquinoicos y sus derivados, composiciones que los incluyen y su utilizacion
BR0111813A (pt) Composições farmacêuticas e produto compreendendo derivados de distamicina acriloìla, e inibidores de topoisomerase i e ii, e seu uso
ATE330958T1 (de) Pyrazino 1&#39;2&#39;:1,6öpyrido 3,4-böindolderivate
MXPA02012911A (es) Compuestos de rutenio (ii) para el uso en terapia del cancer.
TR200302134T4 (tr) 2-metil-tiazolidin-2,4-dikarboksilik asit ve/veya bunun fizyolojik olarak uygun tuzlarının anti-kanser ajanları olarak kullanımı.
ZA200209835B (en) Combined therapy against tumors comprising substituted acryloyl distamycin derivatives, taxanes and/or anti-metabolites.
ID26965A (id) Obat untuk mencegah dan/atau mengobati kanker payudara, yang mengandung inhibitor aromatase steroid
WO2002039958A3 (en) Combination therapy using pentafluorobenzenesulfonamides and antineoplastic agents
BR0215454A (pt) Terapia combinada contra tumores, comprendendo derivados de acriloil-distamicina substituìdos e inibidores de proteìna cinase (serina/treonina cinase)
DE60003189D1 (de) Synergistische zusammensetzung, die daunorubicin derivate und antimetabolite enthält

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8O, 11, 13 E 25 DA LPI.

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.